CMOs and PE Buying Spree for Dose Manufacturing

Buying Spree of CMOs and Private Equity for Dose Manufacturing

According to the GlobalData analysis, some of the largest CMOs are keen on acquiring other corporations despite the hesitancy of general investors during the covid-19 pandemic.

CMOs are collateralized mortgage obligation. It is a type of mortgage-backed security that contains a pool of mortgages bundled together and sold as an investment.

During the 2020 economic crises caused by the pandemic, large CMOs acquired other service providers to increase the production of scale or add new capabilities.

Pharmaceutical companies have long sold manufacturing sites of Europe to CMOs for building capacity. In 2020, pharmaceutical facilities were acquired by large CMOs such as Siegfried Holding AG and Delpharm.

Whereas private equity firms have shown interest in CMOs to supply to markets...

Login In

or

Register now for free access

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments